Navigation Links
ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia

ter the first cycle of atacicept. Accrual and treatment of one additional cohort of B-CLL patients at a higher dose level is ongoing.

Abstract

The abstract is available at http://www.zymogenetics.com in the "What's New" section on the home page.

About Atacicept

ZymoGenetics and Merck Serono, an affiliate of Merck KGaA, Darmstadt, Germany, are developing atacicept (formerly referred to as TACI-Ig) for the treatment of autoimmune diseases and B-cell malignancies. Atacicept contains the soluble TACI receptor that binds to the cytokines BLyS and APRIL. These cytokines are members of the tumor necrosis factor family that promote B-cell survival and autoantibody production associated with certain autoimmune diseases such as systemic lupus erythematosus (SLE). Current data indicates that levels of BLyS and APRIL are elevated in patients with rheumatoid arthritis, SLE and B-cell malignancies. Atacicept has been shown to affect several stages of B-cell development and may inhibit the survival of cells responsible for making antibodies.

About ZymoGenetics

ZymoGenetics creates novel protein drugs with the potential to significantly help patients fight their diseases. The Company is developing a diverse pipeline of potential proprietary product candidates that are moving into and through clinical development. These candidates span a wide array of clinical opportunities that include bleeding, autoimmune diseases and cancer. ZymoGenetics intends to commercialize these product candidates through internal development, collaborations with partners, and out-licensing of patents from its extensive patent portfolio. For further information, visit http://www.zymogenetics.com.

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-
'"/>




Page: 1 2 3

Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
3. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
4. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:3/26/2015)... , March 26, 2015 Zimmer Holdings, Inc. ... new mobile app designed to serve as a feature-rich resource ... product. For those experiencing knee pain, the ... about the causes of knee pain and helps them understand ... a safe and simple non-surgical treatment option. For those who ...
(Date:3/26/2015)... , March 26, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... received a patent acceptance notice from the Israeli patent ... to prevent or reduce tissue damage caused by an ... when cardiac vessels are opened after a blockage causing ... stroke victims. Damage can be caused to ...
(Date:3/26/2015)... InfuSystem Holdings, Inc. (NYSE MKT: INFU), a leading ... healthcare industry in the United States ... secured a new $45.0 million credit facility with JPMorgan Chase ... facility with its prior lender group.  Effective ... senior secured credit agreement comprised of a $10.0 million asset-based ...
Breaking Medicine Technology:Zimmer Launches New Patient Education And Engagement Mobile App For Gel-One Hyaluronate 2RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 2RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 3InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 2InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 3InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 4
... NEW YORK, Feb. 15, 2011 Reportlinker.com ... is available in its catalogue: ... CE countries 2011 - Comparative analysis, reimbursement ... http://www.reportlinker.com/p0395681/Generic-and-innovative-drug-market-in-CE-countries-2011---Comparative-analysis-reimbursement-policies-and-development-forecasts-for-2011-2013 ...
... 15, 2011 Valeant Pharmaceuticals International, Inc. (NYSE: ... a conference call and a live Internet webcast along with ... a.m. ET (7:00 a.m. PT) to discuss results for the ... number to participate on this call is (877) 295-5743, confirmation ...
Cached Medicine Technology:Reportlinker Adds Generic and innovative drug market in CE countries 2011 - Comparative analysis, reimbursement policies and development forecasts for 2011-2013 2Valeant Pharmaceuticals to Announce 2010 Fourth Quarter and Full Year Results on February 24, 2011 2
(Date:3/26/2015)... CO (PRWEB) March 26, 2015 Saving ... help where it is most needed but least available. ... therapeutic milk to six clinics in the Benguela province ... severe malnutrition. During a recent visit to their clinics, ... to the mothers and their babies in a nation ...
(Date:3/26/2015)... San Juan Capistrano, Calif. (PRWEB) March 26, 2015 ... monitoring equipment and repairs, is pleased to be featured ... the Discovery Channel on March 18, 2015. The ... status, and it is live on the Pacific Medical ... families that face life threatening emergencies, it is reassuring ...
(Date:3/26/2015)... Washington DC (PRWEB) March 26, 2015 ... Center for Assessment and Evaluation , has ... technologies that enable institutions, organizations, and corporations to ... to promote successful learning. , Utilizing Questionmark’s ... Testing Services will offer improved delivery of ...
(Date:3/26/2015)... March 26, 2015 Documentation topped ... Nursing and Assisted Living facilities during 2014, despite ... during the year. The survey queried Administrators, ... MDS coordinators, CNA’s and the variety of other ... International website ( http://www.harmony-healthcare.com ) or participate in ...
(Date:3/26/2015)... With the rapidly growing healthcare market and ... care, its not just doctors who are now purchasing ... want a piece of the action. HealthSource Chiropractic ®, ... in franchises purchased by people with no health backgrounds ... , Chiropractic is an exploding $12.7 billion dollar market ...
Breaking Medicine News(10 mins):Health News:Saving Moses Utilized Photography in an Effort to Engage Mothers and Their Babies on a Recent Visit to Angola 2Health News:Pacific Medical Featured on the Discovery Channel 2Health News:Pacific Medical Featured on the Discovery Channel 3Health News:NLN Testing Services Announces Improved Delivery and Analytics Software and Newly Developed and Revised Exams 2Health News:Harmony Healthcare International Releases 2015 Post Acute Care Trends Report 2Health News:Harmony Healthcare International Releases 2015 Post Acute Care Trends Report 3Health News:HealthSource Chiropractic Franchise Expands National Footprint as Investors Buy In 2Health News:HealthSource Chiropractic Franchise Expands National Footprint as Investors Buy In 3
... ... with compliance issues presented by the HITECH Act and its new enforcement regime. , ... Tampa, FL (PRWEB) February 1, 2010 ... RN, BSN, a healthcare and technology thought leader. Given the expanding influence of the ...
... (NIH) Clinical Center are incorporating radiation dose exposure reports ... hope will lead to an accurate assessment of whether ... from medical imaging tests, according to an article in ... American College of Radiology ( JACR ). The ...
... 1 issue of the journal SLEEP found ... people with severe obstructive sleep apnea (OSA). The ... dysfunctions, and dysregulation of autonomic and respiratory control frequently ... changes in brain structure. Results indicate that in ...
... breakthrough in HIV research that had eluded scientists for over ... a study published today in the journal Nature . ... University, have grown a crystal that reveals the structure of ... HIV. When HIV infects someone, it uses integrase to paste ...
... The ... 14 mega-talented artists and technologist from across the country. Combining specialized areas of ... , ... 31, 2010 -- millionants productions, based in the San Francisco Bay Area, offers custom-designed ...
... , ... , - In partnership with World Food Program, agencies ... Vision explains precautions taken to ensure distributions protect families, ... World Vision will join seven other aid agencies today to ...
Cached Medicine News:Health News:DBLG Announces Release 1.0 of the HITECH Act Survival Guide: an Open Source Law Initiative 2Health News:NIH takes step to assess any possible risk associated with low-dose radiation exposure 2Health News:Study finds reduced brain gray matter concentration in patients with severe obstructive sleep apnea 2Health News:HIV researchers solve key puzzle after 20 years of trying 2Health News:millionants productions Launches and is “Making a Scene” 2Health News:World Vision: Vulnerable Must Be First in Line at Launch of City-Wide Food Distributions in Haiti 2Health News:World Vision: Vulnerable Must Be First in Line at Launch of City-Wide Food Distributions in Haiti 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: